Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001231321-25-000003
Filing Date
2025-02-21
Accepted
2025-02-21 20:19:55
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740187189.html 4  
1 FORM 4 wk-form4_1740187189.xml 4 8493
  Complete submission text file 0001231321-25-000003.txt   9961
Mailing Address CARIBOU BIOCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
MCCLUNG BARBARA G (Reporting) CIK: 0001231321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 25653865

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)